CLASSYS Inc.

KOSDAQ:A214150 Stock Report

Market Cap: ₩3.2t

CLASSYS Valuation

Is A214150 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A214150 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A214150 (₩47900) is trading below our estimate of fair value (₩62767.96)

Significantly Below Fair Value: A214150 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A214150?

Key metric: As A214150 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for A214150. This is calculated by dividing A214150's market cap by their current earnings.
What is A214150's PE Ratio?
PE Ratio35x
Earnings₩89.56b
Market Cap₩3.17t

Price to Earnings Ratio vs Peers

How does A214150's PE Ratio compare to its peers?

The above table shows the PE ratio for A214150 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average43.8x
A085370 Lutronic
33.1x26.4%₩949.5b
A145720 Dentium
5.1x13.8%₩503.6b
A336570 WON TECHLtd
16.4x46.6%₩409.2b
A305090 Micro Digital
120.5xn/a₩241.9b
A214150 CLASSYS
35x24.2%₩3.2t

Price-To-Earnings vs Peers: A214150 is good value based on its Price-To-Earnings Ratio (35x) compared to the peer average (43.8x).

Price to Earnings Ratio vs Industry

How does A214150's PE Ratio compare vs other companies in the KR Medical Equipment Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
A035610 Solborn
2.5xn/aUS$68.18m
No more companies available in this PE range
A214150 35.0xIndustry Avg. 12.5xNo. of Companies6PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: A214150 is expensive based on its Price-To-Earnings Ratio (35x) compared to the KR Medical Equipment industry average (12.5x).

Price to Earnings Ratio vs Fair Ratio

What is A214150's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A214150 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio35x
Fair PE Ratio23.5x

Price-To-Earnings vs Fair Ratio: A214150 is expensive based on its Price-To-Earnings Ratio (35x) compared to the estimated Fair Price-To-Earnings Ratio (23.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A214150 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩47,900.00
₩63,533.33
+32.6%
14.8%₩81,000.00₩45,000.00n/a15
Nov ’25₩48,200.00
₩63,285.71
+31.3%
16.2%₩81,000.00₩45,000.00n/a14
Oct ’25₩54,100.00
₩61,071.43
+12.9%
14.1%₩81,000.00₩45,000.00n/a14
Sep ’25₩50,300.00
₩60,142.86
+19.6%
15.1%₩81,000.00₩45,000.00n/a14
Aug ’25₩47,300.00
₩56,428.57
+19.3%
16.1%₩81,000.00₩45,000.00n/a14
Jul ’25₩52,000.00
₩56,428.57
+8.5%
16.1%₩81,000.00₩45,000.00n/a14
Jun ’25₩49,450.00
₩51,666.67
+4.5%
10.9%₩60,000.00₩42,000.00n/a12
May ’25₩37,950.00
₩44,888.89
+18.3%
3.4%₩47,000.00₩42,000.00n/a9
Apr ’25₩38,100.00
₩44,555.56
+16.9%
5.8%₩48,000.00₩40,000.00n/a9
Mar ’25₩32,150.00
₩44,375.00
+38.0%
6.1%₩48,000.00₩40,000.00n/a8
Feb ’25₩29,350.00
₩45,375.00
+54.6%
4.4%₩48,000.00₩41,000.00n/a8
Jan ’25₩37,750.00
₩42,555.56
+12.7%
13.5%₩48,000.00₩30,000.00n/a9
Dec ’24₩41,600.00
₩42,888.89
+3.1%
14.1%₩50,000.00₩30,000.00n/a9
Nov ’24₩33,050.00
₩41,888.89
+26.7%
12.9%₩47,000.00₩30,000.00₩48,200.009
Oct ’24₩37,850.00
₩41,555.56
+9.8%
13.6%₩50,000.00₩30,000.00₩54,100.009
Sep ’24₩38,550.00
₩38,500.00
-0.1%
14.6%₩50,000.00₩30,000.00₩50,300.008
Aug ’24₩29,600.00
₩37,000.00
+25.0%
16.4%₩50,000.00₩30,000.00₩47,300.008
Jul ’24₩32,300.00
₩32,000.00
-0.9%
15.7%₩40,000.00₩24,000.00₩52,000.006
Jun ’24₩27,200.00
₩29,000.00
+6.6%
13.1%₩36,000.00₩24,000.00₩49,450.006
May ’24₩23,700.00
₩25,200.00
+6.3%
3.0%₩26,000.00₩24,000.00₩37,950.005
Apr ’24₩21,750.00
₩24,000.00
+10.3%
3.7%₩25,000.00₩23,000.00₩38,100.005
Mar ’24₩20,400.00
₩24,000.00
+17.6%
3.7%₩25,000.00₩23,000.00₩32,150.005
Feb ’24₩18,390.00
₩23,000.00
+25.1%
2.7%₩24,000.00₩22,000.00₩29,350.005
Jan ’24₩18,400.00
₩26,333.33
+43.1%
28.4%₩43,000.00₩22,000.00₩37,750.006
Dec ’23₩18,850.00
₩26,571.43
+41.0%
26.1%₩43,000.00₩22,000.00₩41,600.007
Nov ’23₩15,700.00
₩27,000.00
+72.0%
25.8%₩42,000.00₩22,000.00₩33,050.006

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Ray

₩102.9b

RAY Co., Ltd. provides x-ray diagnostic equipment in the dental industry.

A228670

₩6,470.00

7D

-0.3%

1Y

-73.4%

Wonbiogen

₩43.7b

Develops and sells medical equipment in South Korea.

A307280

₩1,236.00

7D

0.4%

1Y

-20.8%

Vieworks

₩198.8b

Develops, manufactures, and sells imaging systems and solutions.

A100120

₩21,700.00

7D

5.9%

1Y

-19.5%